Denmark-Israel Bilateral Trade Analysis 2023
Complete trade statistics: $0 total volume •Denmark surplus: $0
Denmark → Israel
$0
Exports (2023)
Israel → Denmark
$0
Imports (2023)
Trade Balance
$0
Surplus for Denmark
Total Trade
$0
Combined Volume
Trade Flow Visualization
Direct trade relationship between Denmark and Israel. Green line shows exports from Denmark, red line shows imports.
Detailed Product Trade Analysis
Comprehensive breakdown of trade flows by product category, revealing the specialized nature of the Denmark-Israel commercial relationship and competitive positioning in global markets.
Denmark → Israel Exports
Export Market Intelligence
🎯 Strategic Export Focus
Denmark's export portfolio to Israel demonstrates strategic specialization, with medicaments: containing hormones (but not insulin), adrenal cortex hormones or antibiotics, for therapeutic or prophylactic uses, packaged for retail sale representing a key competitive advantage in this bilateral market.
Israel → Denmark Imports
Import Dependency Profile
📦 Import Strategy Analysis
Denmark's import pattern from Israel reveals strategic sourcingin medicaments: consisting of mixed or unmixed products n.e.c. in heading no. 3004, for therapeutic or prophylactic uses, packaged for retail sale, highlighting complementary economic structures and potential supply chain optimization opportunities.
Competitive Trade Position Analysis
Market Leadership
Denmark demonstrates competitive strength in exportingmedicaments: containing hormones (but not insulin), adrenal cortex hormones or antibiotics, for therapeutic or prophylactic uses, packaged for retail sale to Israel, leveraging comparative advantages.
Trade Complementarity
The bilateral relationship showsperfectcomplementarity, with each country specializing in different sectors.
Growth Potential
The $0 trade volume indicates substantial economic integration with room for expansion in emerging sectors.
Executive Summary: Denmark-Israel Trade Relationship
Key Trade Highlights 2023
- Total Trade Volume: $0.00representing a significant bilateral economic relationship
- Trade Balance: Denmark maintains a surplus of $0.00
- Export Focus: Denmark's primary exports include medicaments: containing hormones (but not insulin), adrenal cortex hormones or antibiotics, for therapeutic or prophylactic uses, packaged for retail sale, fish fillets: frozen, salmon, pacific (oncorhynchus nerka, oncorhynchus gorbuscha, oncorhynchus keta, oncorhynchus tschawytscha, oncorhynchus kisutch, oncorhynchus masou, oncorhynchus rhodurus), atlantic (salmo salar), and danube (hucho hucho), fish fillets: fresh or chilled, salmon, pacific (oncorhynchus nerka, oncorhynchus gorbuscha, oncorhynchus keta, oncorhynchus tschawytscha, oncorhynchus kisutch, oncorhynchus masou and oncorhynchus rhodurus), atlantic (salmo salar), danube (hucho hucho)
- Import Dependencies: Key imports from Israel include medicaments: consisting of mixed or unmixed products n.e.c. in heading no. 3004, for therapeutic or prophylactic uses, packaged for retail sale, electronic integrated circuits: n.e.c. in heading no. 8542, rubber: new pneumatic tyres, of a kind used on agricultural or forestry vehicles and machines
Strategic Trade Indicators
📈 Market Position: This bilateral trade relationship represents an important regional trade partnerships, with complementary economic strengths driving sustained commercial exchange.
Historical Trade Analysis & Economic Context
Trade Evolution Timeline
2019-2023: Recent Trends
Current trade volume of $0 represents the culmination of evolving bilateral commercial relationships, influenced by global supply chain shifts and changing economic priorities.
2015-2019: Growth Period
Sustained expansion in bilateral trade driven by complementary economic structures, with Denmark leveraging its comparative advantages in medicaments: containing hormones (but not insulin), adrenal cortex hormones or antibiotics, for therapeutic or prophylactic uses, packaged for retail sale.
2010-2015: Foundation Building
Establishment of modern trade frameworks and reduction of barriers, facilitating increased commercial exchange and investment flows between the two economies.
Pre-2010: Early Development
Initial stages of bilateral trade relationship development, with focus on traditional export-import patterns and gradual market integration.
Key Economic Drivers
Comparative Advantage
Denmark's specialization in medicaments: containing hormones (but not insulin), adrenal cortex hormones or antibiotics, for therapeutic or prophylactic uses, packaged for retail salecomplements Israel's demand patterns, creating natural trade synergies.
Supply Chain Integration
Deep integration in global value chains has strengthened bilateral linkages, particularly in medicaments: consisting of mixed or unmixed products n.e.c. in heading no. 3004, for therapeutic or prophylactic uses, packaged for retail sale.
Market Access & Trade Policy
Favorable trade agreements and market access conditions have facilitated the growth of this $0 bilateral relationship.
Trade Pattern Insights
Trade Relationship Outlook
The $0 bilateral trade volume positions this relationship for continued growth, supported by technological advancement, evolving consumer preferences, and strengthening economic ties. Key opportunities lie in expanding cooperation in emerging sectors while managing potential supply chain vulnerabilities.
Economic Impact & Strategic Outlook
Economic Impact Assessment
Trade Volume Impact
The $0.00 bilateral trade volume represents a important trade relationshipfor both economies.
Industrial Integration
Trade flows in medicaments: containing hormones (but not insulin), adrenal cortex hormones or antibiotics, for therapeutic or prophylactic uses, packaged for retail sale and medicaments: consisting of mixed or unmixed products n.e.c. in heading no. 3004, for therapeutic or prophylactic uses, packaged for retail sale demonstrate deep industrial linkages and supply chain integration.
Trade Balance Effects
Denmark's trade surplus of $0.00 strengthens its overall economic position in this bilateral relationship.
Strategic Future Outlook
🚀Growth Opportunities
⚠️Risk Factors
🎯Strategic Recommendations
- Strengthen cooperation in high-value sectors beyond current trade patterns
- Develop alternative supply chains to reduce dependency risks
- Explore joint ventures in emerging technology sectors
- Enhance trade facilitation and reduce transaction costs
Market Position & Competitive Summary
The bilateral trade relationship between Denmark and Israel represents a total trade volume of $0.00 in 2023. This partnership demonstrates a favorable trade balance for Denmark, with exports exceeding importsby $0.00.
Export Strengths
Denmark's exports to Israel total $0.00, with competitive advantages in medicaments: containing hormones (but not insulin), adrenal cortex hormones or antibiotics, for therapeutic or prophylactic uses, packaged for retail sale, representing $134.24M orInfinity% of bilateral exports.
Import Dependencies
Imports from Israel amount to $0.00, highlighting economic interdependence in medicaments: consisting of mixed or unmixed products n.e.c. in heading no. 3004, for therapeutic or prophylactic uses, packaged for retail sale, with Medicaments: consisting of mixed or unmixed products n.e.c. in heading no. 3004, for therapeutic or prophylactic uses, packaged for retail sale comprisingInfinity% of total imports.
The trade relationship reflects broader economic patterns and comparative advantages. The trade surplus indicates Denmark's competitive position in this bilateral relationship. This partnership is characterized by complementary trade flows, with each country specializing in different product categories based on their respective economic strengths, industrial capabilities, and position in global value chains.
Download Bilateral Trade Data
Access detailed trade data between Denmark and Israel in multiple formats.
Data Source: CEPII BACI (Base pour l'Analyse du Commerce International) • Last Updated: January 2025 • Coverage: 1995-2023